The US FDA process to force the withdrawal of the pre-term labor drug Makena is in its final stages. The product seems likely to finally leave the market – but may also demonstrate that there is a business to be built in contesting FDA withdrawal proceedings.

Deals show large investors’ appetite for early-stage biotech, but can VC and PE rub along?

Tensys Medical Inc. aims to be the first to effectively penetrate the $1 billion worldwide continuous noninvasive blood pressure management market. Its T-Line incorporates a pressure sensor placed over the radial artery to provide real-time beat-to-beat measurement of a patient's blood pressure during surgery.